Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
Autoimmune & Inflammation CRO Services
Drive your immunology drug development forward with Cyagen's comprehensive CRO solutions for autoimmune and inflammatory diseases. Benefit from our proven models and expert support to expedite your path to therapeutic breakthroughs.
One-Stop Autoimmune & Inflammation CRO Solutions
Cyagen provides one-stop CRO solutions for autoimmune and inflammation drug discovery, offering both genetically engineered and induced disease models alongside full-spectrum in vivo and in vitro efficacy services. With extensive experience in modeling RA, SLE, IBD, and other disorders, our platform supports both basic research and translational studies — delivering data-driven insights for IND submissions and therapeutic innovation.
{{ item.title }}
{{static_tabs[0].title}}
Cyagen offers a wide selection of validated autoimmune and inflammatory disease models, including both genetically engineered and chemically induced mouse models. These models support translational research across diseases like rheumatoid arthritis, psoriasis, systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), and more.
Base Strain
Search for Models
Search
Catalog Number Name Base Strain Research Application Action
{{ value.product_num || "--" }} {{ value.product_name || "--" }} {{ value.product_strain || "--" }}
;
Inquire
+
Previous Page
Next Page
Can't Find Your Model?
If your desired model isn't listed, our experts are here to help! Request a Custom Animal Model >>
{{static_tabs[1].title}}
We provide in vivo pharmacodynamic services tailored to autoimmune and inflammatory disease research. Our robust model systems and optimized study protocols help assess treatment efficacy under clinically relevant conditions.
Model Customization
Genetically engineered (e.g., Il10 KO, Tlr4 KO) and chemically induced (e.g., IMQ-induced psoriasis, DSS-induced IBD) models available.
Disease-Specific Endpoints
Weight change, organ index, PASI scoring, proteinuria, anti-dsDNA levels, and histopathological scoring.
Multimodal Validation Tools
  • Histology: H&E, IHC, and IF
  • Biochemical assays: ELISA, qPCR
  • Immune profiling: Flow cytometry
  • Imaging-based assessments
Need customized disease models or scoring endpoints for your study?
Request Custom In Vivo Services →
{{static_tabs[2].title}}
Verify treatment efficacy and mechanism of action through detailed tissue-level analysis and molecular assays. Cyagen provides end-to-end solutions for ocular histopathology, molecular profiling, and biomarker validation—supporting your IND filings with reliable, publication-ready data.
Immunoassays
  • ELISA for cytokines and antibodies (e.g., anti-dsDNA, IgE)
  • Multiplex cytokine profiling (Luminex/MSD/FACS)
Pathology & Imaging
  • H&E, IHC, and IF analysis for inflamed tissues (skin, kidney, lung, joints)
Molecular Tools
  • RNA extraction, qPCR, WB for target validation
Flow Cytometry
  • For T/B/NK cell profiling, Th1/Th2/Th17 balance, activation markers
Need help with histopathology or cytokine biomarker analysis?
Request Analytical Services →
Case Examples
{{ item.label }}
{{v2.label}}
{{item.context}}
{{v2.context}}
{{item.title}}
{{ item.context }}
Related Resources
Events & Webinars
Beyond the mouse: Accelerating Drug Discovery for Obesity & T2D with HUGO-GT™
View Details
Promotional Campaign
Flash Drop — Ready-to-Ship KO/cKO Mice
View Details
Blogs & Insights
Why Eli Lilly is Targeting Nav1.8 and MNK for Next-Gen Pain Therapeutics
View Details
Resource Valut
Development of Fully Human Anti-ACVR2A Antibodies with Enhanced Selectivity and Favorable Pharmacokinetics for Metabolic and Muscle Disorders
View Details
Request a Preclinical CRO Services Consultation
Partner with Cyagen to advance your preclinical studies. Share your project goals with us and receive customized support.
Inquiry Details
Main Area of Research
Service(s) of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research